Detalhe da pesquisa
1.
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Cancer
; 129(15): 2308-2320, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078412
2.
A tissue-specific chromatin loop activates the erythroid ankyrin-1 promoter.
Blood
; 120(17): 3586-93, 2012 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22968456
3.
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.
Blood Adv
; 8(2): 429-440, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871309
4.
Real-world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system.
Cancer Med
; 12(17): 18368-18380, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635639
5.
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates.
Blood Adv
; 7(11): 2360-2363, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315007